Related Experiment Videos
Angiotensin antogonists as pharmacological tools
Federation Proceedings
|November 1, 1976
Summary
Angiotensin antagonists, by blocking specific receptors, show therapeutic potential in treating hemorrhagic shock. These agents can reduce vascular resistance and improve organ perfusion, particularly in the kidneys.
Area of Science:
- Pharmacology
- Cardiovascular Physiology
- Renal Physiology
Background:
- The physiological and pathological roles of angiotensin (A-II) have been extensively investigated.
- Specific competitive antagonists have enabled detailed characterization of angiotensin receptor sites.
- Angiotensin II plays a crucial role in smooth muscle contraction and prostaglandin release.
Purpose of the Study:
- To investigate the physiological and pathological roles of angiotensin II.
- To characterize angiotensin receptor sites using competitive antagonists.
- To evaluate the therapeutic potential of angiotensin antagonists in hemorrhagic shock.
Main Methods:
- Utilized specific competitive antagonists for angiotensin II.
- Examined the effects of angiotensin antagonists on isolated smooth muscle preparations.
- Assessed the impact of converting enzyme inhibitors and angiotensin receptor antagonists on blood pressure and bradykinin activity.
Main Results:
- Angiotensin II antagonists inhibit direct A-II actions on smooth muscle and prostaglandin release.
- Converting enzyme inhibitors block A-I action and lower blood pressure in high renin states but do not affect A-II receptor sites.
- Angiotensin receptor antagonists block both A-I and A-II actions, lower blood pressure in high renin states, and decrease peripheral resistance, reversing renal vasoconstriction in shock.
Conclusions:
- Angiotensin antagonists demonstrate significant therapeutic potential for managing hemorrhagic shock.
- These agents can overcome vascular shutdown and enhance organ perfusion, especially in the kidneys.
- Combination therapy with alpha-adrenergic blockade may further improve outcomes in shock.